venetoclax,ivosidenib,azacitidine
roche,abbvie,servier
['ivosidenib', 'venetoclax', 'leukemia', 'leusm']
congress #asco22 |curtis andrew lachowiez reports on a phase ib/ii study of ivosidenib &amp; venetoclax +/- aza in idh1 mutated haem malignancies. 24 month os for mrd -ve patients was 100%, median os nr. mrd +ve patients had a median os of 8 months #leusm #leukemia 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm